What Can You Expect in 2026?
The mRNA Analytical Development & Quality Control Summitstood as the world’s only forum dedicated exclusively to strengthening analytical and quality frameworks across the entire mRNA product lifecycle.
As the field diversified beyond vaccines into therapeutic applications spanning oncology, infectious disease, and gene editing, the need for robust, phase‑appropriate analytical strategies had never been greater.
Throughout the meeting, attendees gained actionable insights into method development, validation, characterization, and release testing, empowering teams to ensure product integrity, regulatory compliance, and manufacturing readiness. This interactive forum brought together leaders in Analytical Development, Quality Control, CMC, Regulatory Affairs, and Process Development to address the industry’s most urgent challenges, from standardizing potency assays and managing dsRNA impurities to establishing globally harmonized control strategies.
Advance mRNA Therapeutics from Discovery to Release - Key Focus Areas
Join Europe’s first dedicated community for mRNA analytical excellence - where regulators, innovators, and analytical leaders unite to set the benchmark for quality, reproducibility, and clinical success.
Draft Guidelines & Reference Standards
Navigating new draft guidelines and reference standards from EMA, FDA, USP, and NIST to enhance analytical robustness and regulatory alignment
End-to-End AD/QC Integration
Establishing end-to-end AD/QC integration to enable seamless technology transfer and phase-specific readiness.
Analytical Platforms & AI-Driven Workflows
Harnessing novel analytical platforms and AI-driven workflows to increase sensitivity, accuracy, and throughput.
QC Strategies
Defining QC strategies for emerging modalities - including circular RNA, self-amplifying RNA, and novel delivery systems.
2026 Event Highlights
Assay Automation
Discovered how automation and digitalization are streamlining analytical workflows and reducing variability across development and QC.
Real-Time Analytics
Learnt how emerging real-time monitoring technologies are transforming process understanding and accelerating decision-making.
Pre-QC Strategies
Bridged the gap between analytical development and QC through phase-appropriate design and data-driven readiness frameworks.
Evolving Regulations
Gained direct insight into the latest draft guidance and reference standards from EMA, FDA, USP, and NIST - and what they mean for your CMC submissions.
Stability Studies
Explored advanced stability testing methods and predictive modelling to extend product shelf life and ensure consistent performance.
Explore The 2026 Full Event Guide
- Exclusive Regulatory Workshop lead by US Pharmacopeia
- 10+ case studies on novel ADQC methods
- Unrivalled Networking Opportunities
- 18+ World Class Expert Speakers
- The world’s only forum exclusively focussed on Analytical Development & Quality Control
Companies That Attended Include
Explore the Agenda
Dive into cutting-edge mRNA ADQC, that are both phase-appropriate and aligned with early to late stage settings.
Partner With Us
Showcase your technologies and services to decision-makers actively seeking and driving next-generation mRNA therapeutics.
Join mRNA Leaders
Be part of the only forum uniting leading pharma, biotech, academia and regulatory experts